Mobile iris recognition
Iris recognition is thought to be the highest-accuracy, single-factor biometric identification in the world, and could have many uses.
In November, for example, an iris recognition system was installed in Bad Reichenhall’s city hospital to protect access to the infants’ ward.
The developers Byometric Systems Inc, of Mitterfelden, Germany, in co-operation with the University of Applied Science, Salzburg, Austria, report that over 240 degrees of the human iris is examined, to create a 512-byte data template, used to identify individuals and/or authenticate user privileges.
In future, another application could be to identify unconscious patients, who cannot give information about chronic disease. Alexander Lau, CEO of Byometric Systems said that the image of the Iris would be transferred to a computer, to send a unique IrisCode to a central database, where the patient would be identified. Data relayed to the attending doctor could then be used in treatment decisions.
This article was published on 07/01/2003
Search
Service
Company News
Meet us at MEDICA! Hall 7 Stand 15
The European Hospital team will be happy to hear about your research, products, R&D or trials and launches, hospital management issues, or any other aspects of your work, so that we can discuss your editorial ideas. We will also be pleased to help with any PR or advertising queries.
Products redesigned to help patients simplify life with diabetes
Bayer HealthCare Diabetes Care unveiled the new
CONTOUR® blood glucose meter with enhanced testing features at the 44th Annual Meeting of the European Association for the Study of Diabetes in Rome, Italy.
Technical infrastructure for EU funded R-bay project
Carestream Health is a major technical infrastructure provider to the EU-funded R-Bay validation project, which aims to address the uneven spread of radiologists across member states. CARESTREAM Radiology and Information Management Solutions are driving the initial test platform for the project by facilitating remote reporting of images from hospitals in Denmark, Finland and Czech Republic by clinical providers in Estonia, Lithuania and the Netherlands.
